1. A regulatory authority’s opinion about surrogate endpoints;Temple,1995
2. On the use of laboratory markers as surrogates for clinical endpoints in the evaluation of treatment for HIV infection;Machado;J Acquir Immune Defic Syndr,1990
3. Surrogate end points in clinical trials;Fleming;Ann Intern Med,1996
4. Surrogate endpoints in clinical trials;Prentice;Stat Med,1989
5. Statistical validation of intermediate endpoints for chronic diseases;Freedman;Stat Med,1992